Adults with inflammatory diseases who received TNF-I were at a greater risk for several skin cancer types compared with those who did not use TNF-I.

Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid arthritis (RA) are unfounded, at least for U.S. military veterans, a new study ...

Long-term research indicates that starting rheumatoid arthritis patients on targeted biologic drugs like TNF inhibitors from diagnosis may reduce or delay progression to difficult-to-treat disease, ...

Patients with axial spondyloarthritis (axSpA) treated with tumor necrosis factor (TNF) inhibitors were at significantly lower risk for hip and spine fractures compared with those receiving only ...

STOCKHOLM — Predictors of primary nonresponse and loss of response to anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease (IBD), including demographic, biochemical, and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with axial SpA treated with TNF inhibitors had ...

R Dr Eneas de Carvalho Aguiar 470, Instituto de Medicina Tropical (IMT), Cerqueira Cesar, São Paulo, SP, 05403 903, Brazil Tel.: +55 11 3061 7457 Fax: +55 11 3081 7190 mahong@usp.br Establishing that ...

Drug retention is similar with second-line IL-17 inhibitors vs TNF inhibitors among patients with axSpA who discontinued their initial TNF inhibitor.